Cargando…
Safety and efficacy of a wireless pulmonary artery pressure sensor: primary endpoint results of the SIRONA 2 clinical trial
AIMS: Implantable pulmonary artery pressure (PAP) sensors have been shown to reduce heart failure hospitalizations (HFH) in selected patients. The goal of this study was to evaluate the safety and efficacy of a novel wireless PAP monitoring system in patients with heart failure (HF). METHODS AND RES...
Autores principales: | Sharif, Faisal, Rosenkranz, Stephen, Bartunek, Jozef, Kempf, Tibor, Assmus, Birgit, Mahon, Niall G., Mullens, Wilfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715805/ https://www.ncbi.nlm.nih.gov/pubmed/35686479 http://dx.doi.org/10.1002/ehf2.14006 |
Ejemplares similares
-
Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first‐in‐human study
por: Mullens, Wilfried, et al.
Publicado: (2020) -
Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
por: Teichgräber, Ulf, et al.
Publicado: (2021) -
Endpoints in stem cell trials in ischemic heart failure
por: Banovic, Marko, et al.
Publicado: (2015) -
A Wireless and Passive Low-Pressure Sensor
por: Nicolay, Pascal, et al.
Publicado: (2014) -
Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trial
por: Störk, Stefan, et al.
Publicado: (2022)